APG system

Study Links Key Gene to Protection from Severe Illness and Death From Covid Infections in Men Under Age 75

Retrieved on: 
Wednesday, March 13, 2024
Inflammation, Gene, Brain, Letter, Internal medicine, Rheumatoid arthritis, COVID-19, NYU Langone Health, Infection, Disease, Abramson, Risk, Patient, APG system, Journal, Research, IL1, Factorization of polynomials, Canakinumab, NYU, Death, Doctor of Philosophy, SARS-CoV-2, Attur, Salem, Arthritis, Woman, Male, MPH, National Institutes of Health, IL1RN, Vasopressin receptor 2, Bangladesh Technical Education Board, Fatigue, Blood, Viral, Hospital, Pharmaceutical industry

NEW YORK, March 13, 2024 /PRNewswire/ -- A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows.

Key Points: 
  • NEW YORK, March 13, 2024 /PRNewswire/ -- A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows.
  • According to the study authors, the protective gene in question, an interleukin-1 receptor antagonist (IL1RN) variant, appears to tamp down inflammation.
  • Overall, more men than women (240 men, at 60.5%; and 157 women, at 39.5%) died from their disease, with women 20% less likely to die than men.
  • Funding support for this study was provided by National Institutes of Health grants P30CA016087 and R21AR078466.

The Toy Association™ Announces 2024 Toy Trends

Retrieved on: 
Thursday, February 8, 2024
Bandai, One Piece, Social media, Sport, Crunchyroll, White, Emotional intelligence, Toy Association, Minecraft, Stranger Things, APG system, Social, The Walt Disney Company, Parenting, Creativity, Fantasy, Video, Physical fitness, Marketing, Literature, Child, Summer Olympic Games, Netflix, Parent, Research, Curriculum, Toy

NEW YORK, Feb. 8, 2024 /PRNewswire/ -- From spooky, sustainable, and anime-inspired playthings, to holistic toys that give young minds and bodies a boost, The Toy Association™ today unveiled the top trends expected to drive consumer spending on toys, games, and youth entertainment products in 2024. The announcement was made during The Toy Association's annual Toy Trends Briefing, a virtual press conference that gave retailers and media a first look at the latest developments in toys and play.

Key Points: 
  • The announcement was made during The Toy Association's annual Toy Trends Briefing, a virtual press conference that gave retailers and media a first look at the latest developments in toys and play.
  • The Toy Association's team of trend experts meets with hundreds of global toy companies throughout the year to track the latest developments in toys, play, and youth entertainment, as well as parallel industries.
  • A summary of the top 2024 trends follows:
    Forty-five percent of parents under the age of 40 consider a toy's environmental impact when making buying decisions, according to a Toy Association survey of U.S. parents.
  • A fervent global fandom is bringing anime to the forefront in 2024, and its impact on the toy space is expected to reach unprecedented heights.

FHLB Dallas, Home Bank, Fifth District Savings Bank, Red River Bank and Trustmark to Award Nearly $4M in Affordable Housing Funds to Gulf Coast Housing Partnership

Retrieved on: 
Friday, February 2, 2024
Professional Services, Philanthropy, Residential Building & Real Estate, Other Philanthropy, Fund Raising, Construction & Property, Banking, Multimedia, Home Bank, APG system, Trustmark, Rehabilitation, Congress, FHLB, Housing, CRA, AHP, Federal Home Loan Banks, Organization, Management

The Federal Home Loan Bank of Dallas (FHLB Dallas) awarded $3.98 million through members Home Bank, Fifth District Savings Bank, Red River Bank and Trustmark to Gulf Coast Housing Partnership (GCHP).

Key Points: 
  • The Federal Home Loan Bank of Dallas (FHLB Dallas) awarded $3.98 million through members Home Bank, Fifth District Savings Bank, Red River Bank and Trustmark to Gulf Coast Housing Partnership (GCHP).
  • The Affordable Housing Program (AHP) grants will support seven affordable housing projects in Louisiana and Mississippi.
  • View the full release here: https://www.businesswire.com/news/home/20240202331974/en/
    Brian North, Kelvin Luster, Kathy Laborde, Jannease Seastrunk and Bruce Hatton celebrate $3.98M in Affordable Housing Program funds from FHLB Dallas and member banks.
  • “We are grateful to FHLB Dallas, Red River Bank, Trustmark, Home Bank and Fifth District Savings Bank,” she said.

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

Retrieved on: 
Friday, January 26, 2024
APG system, Family, Woman, Infertility, UC, UC Davis Medical Center, University, Food and Drug Administration, University of California, Davis, Safety, FDA, Obstetrics, Medical Center, Clinical trial, Lead, Pharmaceutical industry

UC Davis Medical Center, a top regional and nationally ranked medical center, is the third academic center to participate in the FemBloc pivotal trial since enrollment began last quarter -

Key Points: 
  • UC Davis Medical Center, a top regional and nationally ranked medical center, is the third academic center to participate in the FemBloc pivotal trial since enrollment began last quarter -
    UC Davis Professor of the Obstetrics and Gynecology (OB/GYN) Department and Director of the Complex Family Planning Fellowship, Mitchell Creinin, M.D.
  • The FemBloc Intratubal Occlusion for TranscervicAL Permanent Birth Control (the “FINALE” trial) is being conducted to investigate the safety and efficacy of its investigational permanent birth control candidate, FemBloc®.
  • The FDA-approved, multi-center trial is designed to address the high unmet need that exists for women seeking permanent birth control, for whom elective surgery currently remains the only option.
  • “I believe that this may be an ideal solution for those seeking an accessible, safe, less financially and emotionally burdensome option to address a basic healthcare need for family planning.”

Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis

Retrieved on: 
Tuesday, November 14, 2023
Regeneron Pharmaceuticals, Osteoporosis, Research, Albany Medical College, UCB, Osteoarthritis, Disease, Tissue, Clinical trial, Teaching hospital, Internal medicine, Patient, Bristol Myers Squibb, Reiko True, AbbVie, Arthritis, Joint, Rheumatology, Health, Abstract, North Shore University Hospital, Pain, Janssen, APG system, Rheumatism, Confusion, GSK plc, HIV disease progression rates, Inflammation, Amgen, Cryptocurrency, Pharmaceutical industry, Pfizer, Rheumatoid arthritis, Takeda, Genentech

is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.

Key Points: 
  • is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.
  • The company has now enrolled about 33% of the 210 patients it is recruiting for a Phase II, Double-Blind, Placebo-Controlled, Randomized study, examining Natrunix in combination with methotrexate for the treatment of Rheumatoid Arthritis.
  • I am excited to be part of a clinical trial program studying a novel approach to RA.”
    Dr. Kivitz has had a prodigious medical career treating arthritis and rheumatic diseases.
  • Dr. Kivitz has authored over 500 research articles, abstracts, and clinical studies relating to osteoarthritis, osteoporosis and rheumatoid arthritis and has lectured on his findings around the world.

Baldwin Brothers Funeral & Cremation Society Opens New Location in Tarpon Springs

Retrieved on: 
Thursday, November 16, 2023
Spring, Cremation, Burial, APG system, Brother, Life, Palm Harbor, Florida, Video game, Life insurance

TARPON SPRINGS, Fla., Nov. 16, 2023 /PRNewswire-PRWeb/ -- Baldwin Brothers Funeral & Cremation Society of Florida proudly announces the opening of their new location in Tarpon Springs. The facility, which began operations in October, is located at 39346 US Hwy 19 N, Tarpon Springs, FL 34689.

Key Points: 
  • TARPON SPRINGS, Fla., Nov. 16, 2023 /PRNewswire-PRWeb/ -- Baldwin Brothers Funeral & Cremation Society of Florida proudly announces the opening of their new location in Tarpon Springs.
  • Baldwin Brothers has been serving local communities since 1980, offering compassionate and personalized funeral and cremation services.
  • Their Tarpon Springs location is equipped with modern amenities and a dedicated staff ready to assist with all funeral and cremation needs.
  • For more information or to make arrangements, contact Baldwin Brothers Funeral & Cremation Society at (727)-290-2015 or via email at [email protected] .

God Can Lead From Challenge to Triumph - Even When Hope is Lost

Retrieved on: 
Thursday, October 26, 2023
Health, Heart, Trauma, Life, Hope, Reading, Swimming, Singing, Abuse, Darkness, Salem Media Group, Multimedia, Xulon Press, Amazon, Injury, Lord, APG system, Love, ELK, Minneapolis–Saint Paul, Imperial Noble Consort, Book, Entertainment

ELK RIVER, Minn., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Author Jannyce Barnes shares her inspirational personal memoir to provide hope to anyone looking for answered prayers in Warrior in the Making: Armed with His Truth ($38.49, paperback, 9781662887345; $9.99, e-book, 9781662887352).

Key Points: 
  • The love and grace of Christ and how he fixed my brokenness and transformed my life is the passion behind it.
  • Barnes shares her emotional and relatable story along with powerful insights to provide readers hope and encouragement to endure, face their demons, and trust that God can lead them to a better life.
  • Her personal journey is one of hope during a colorful and wonderful life mixed with the bizarre, the traumatic, and the painful.
  • Allowing God to lead truly awakened her warrior spirit and took her faith to a new level – transforming both her mind and life.

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

Retrieved on: 
Tuesday, August 8, 2023
NRS, ACR, APG system, RA, Arthritis, Interleukin-1 family, Enterprise master patient index, Arthritis Foundation, Quality of life, American College of Rheumatology, Tenderness, Inflammation, Person, Rheumatoid arthritis, CDC, Pain, Joint, American College, Phase, CDAI, MTX, Safety, Pharmaceutical industry

AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.

Key Points: 
  • AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.
  • Natrunix blocks a key cause of inflammation involved in pain and joint destruction in rheumatoid arthritis (RA).
  • The primary endpoint of the Phase II is the American College of Rheumatology (ACR) 20% Response (ACR 20) rate at 12 weeks.
  • In addition, it is expected that 300,000 children will suffer from juvenile arthritis (Arthritis Foundation, 2023).

Dobbs vs. Jackson Women’s Health Organization Anniversary Statement

Retrieved on: 
Tuesday, June 27, 2023
Knowledge, Learning, Travel, Violence, Education, Professional, Public, Abortion, Human, Dobbs, Medicine, Infertility, Judgement, Certification, American Board of Commissioners for Foreign Missions, Patient, Physician, Supreme court, Fellows, Supreme, City, Nursing care plan, APG system, Health, American Board of Obstetrics and Gynecology, ABOG, Birth control, Nursing, Obstetrics, Gynaecology

Dallas, TX, June 27, 2023 (GLOBE NEWSWIRE) -- On June 24, 2022, the Supreme Court of the United States issued the Dobbs vs. Jackson Women’s Health Organization decision that overturned decades of constitutionally protected abortion access in the United States.

Key Points: 
  • Dallas, TX, June 27, 2023 (GLOBE NEWSWIRE) -- On June 24, 2022, the Supreme Court of the United States issued the Dobbs vs. Jackson Women’s Health Organization decision that overturned decades of constitutionally protected abortion access in the United States.
  • The education and training of residents and fellows in Obstetrics and Gynecology (OB GYN) have been challenged by the variation in state laws restricting reproductive health care.
  • Patients must trust that their physicians can and will provide critical health care without legislative interference in personal decision making.
  • Assessment of knowledge, judgment, and skills in reproductive health care including abortion are part of the OB GYN and subspecialty certification standards.

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

Retrieved on: 
Thursday, June 8, 2023
BSE, APG system, Plaque, Arthritis, Icahn School of Medicine at Mount Sinai, Physician, Stroke, NYU, Cancer, New York University Grossman School of Medicine, Type 2 diabetes, Woman, Research, Alzheimer's disease, Artery, Inflammation, Cell, Doctor of Philosophy, National Institutes of Health, Atherosclerosis, Bangladesh Technical Education Board, Lung, MS, Saracatinib, Blood, NYU Langone Health, Plasma, Protein, Patent, Patient, Pathology, Rabbit, Kent, Mouse, ASCVD, Moyamoya disease, Cytokine, Integration, Gene, NIH, Safety, Disease, Pharmaceutical industry, Vaccine, Medicine, MD

NEW YORK, June 8, 2023 /PRNewswire/ -- An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

Key Points: 
  • NEW YORK, June 8, 2023 /PRNewswire/ -- An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.
  • As this buildup hardens into plaques and causes misplaced immune reactions (inflammation), it can block blood flow to cause heart attack or stroke.
  • Further experiments then showed that the drug saracatinib reduced this inflammation signaling by more than 90% in human blood samples and diseased tissue samples.
  • Physicians prescribe statins to reduce harmful fats in the blood, but studies show that even with reduced plaque deposits, inflammation persists in many patients, who remain at high risk for heart attack.